Clinical Trials Directory

Trials / Completed

CompletedNCT00579540

Compare Effects of Flax Seed Oil, and Fish Oil on Blood Sugar Levels

CCRC: Prevention of Post-Prandial Hypoglycemia Using n-3/n-6 PUFA in PCOS

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
66 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Flax seed oil, fish oil, and soy bean oil, are commonly recommended supplements for Polycystic Ovarian Syndrome (PCOS). These oils have different chemical structures and biological actions. It is not yet known which of these oils has the most beneficial effects in PCOS patients because they have never been compared to each other head to head. In this study the researchers hope to learn more about the effects of these oils on blood sugar and insulin levels.

Detailed description

The aim is to investigate whether n-3 PUFA's can be used to prevent postprandial hypoglycemia and its unfavorable consequences, such as stimulation of cortisol and adrenal androgen secretion, in women with polycystic ovarian syndrome.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFlax Seed OilSubject will follow their usual diet for 4 weeks, at week 6 they will be randomized to receive either flax seed oil, fish oil, or soybean oil capsules for 6 weeks. They will take six capsules orally six times a day for a total of six weeks.
DIETARY_SUPPLEMENTFish OilSubject will follow their usual diet for 4 weeks, at week 6 they will be randomized to receive either flax seed, fish oil, or soybean oil capsules for 6 weeks. They will take six capsules orally six times a day for a total of six weeks.
DIETARY_SUPPLEMENTSoybean OilSubject will follow their usual diet for 4 weeks, at week 6 they will be randomized to receive either flax seed, fish oil, or soybean oil capsules for 6 weeks. They will take six capsules orally six times a day for a total of six weeks.

Timeline

Start date
2007-09-01
Primary completion
2009-09-01
Completion
2009-09-01
First posted
2007-12-24
Last updated
2017-05-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00579540. Inclusion in this directory is not an endorsement.